Consolidated Income Statements - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2015		Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net sales	$ 8,595		$ 9,706	$ 17,767	$ 19,834
Other income, net	283		408	481	425
Total	8,878		10,114	18,248	20,259
Cost of goods sold	5,280		5,999	10,833	11,999
Other operating charges	349		300	632	586
Selling, general and administrative expenses	1,371		1,473	2,683	2,909
Research and development expense	515		545	1,014	1,063
Interest expense	127	[1]	94	211	197
Employee separation / asset related charges, net	61		263	99	263
Total	7,703		8,674	15,472	17,017
Income before income taxes	1,175		1,440	2,776	3,242
Provision for income taxes	230		366	796	723
Net income	945		1,074	1,980	2,519
Less: Net income attributable to noncontrolling interests	5		4	9	10
Net income attributable to DuPont	$ 940		$ 1,070	$ 1,971	$ 2,509
Basic earnings per share of common stock	$ 1.04		$ 1.16	$ 2.17	$ 2.72
Diluted earnings per share of common stock	1.03		1.15	2.15	2.70
Dividends per share of common stock	$ 0.49		$ 0.45	$ 0.96	$ 0.90

[1] Included transaction costs of $(20) in the three months ended June 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015. These costs were recorded in interest expense, in the company's interim Consolidated Income Statements.